Comoretto, Rosanna Irene http://orcid.org/0000-0002-8601-1899
,
Rea, Federico
Lucenteforte, Ersilia
Mugelli, Alessandro
Trifirò, Gianluca
Cascini, Silvia
Roberto, Giuseppe
Chinellato, Alessandro
Filippelli, Amelia
Corrao, Giovanni
Funding for this research was provided by:
AIFA (FARM9LBBBL)
Article History
Received: 12 February 2018
Accepted: 23 April 2018
First Online: 7 May 2018
Compliance with ethical standards
:
: EL received research support from the Italian Agency of Drug (AIFA) that is not related to this study. AM received research support from the Italian Agency of Drug (AIFA), the Italian Ministry for University and Research (MIUR), Gilead, and Menarini. In the last 2 years, he received personal fees as speaker/consultant from Menarini Group, IBSA, Molteni, Angelini and Pfizer Alliance. None of these is related to this study. GT leads an academic pharmacoepidemiology team which runs project that are sponsored by pharmaceutical companies and that are not related to the topic of the paper. GC received research support from European Community (EC), European Medicine Agency (EMA), Italian Agency of Drug (AIFA), High Health Institute (ISS), Ministry for Health, and University and Research. He took part to a variety of projects that were funded by pharmaceutical companies (i.e., Novartis, GSK, Roche, AMGEN, and BMS). He also received honoraria as member of Advisory Board from Roche. None of these is related to this study. RIC, FR, LS, SC, GR, AC, and AF declare that they have no conflict of interest.
: For this type of study, formal consent is not required.